Back

The incidence and clinical significance of de novo depression after shock delivery in cardiac resynchronization therapy recipients.

30 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Optimising results of cardiac resynchronisation therapy and clinical results and left ventricular lead placement Resynchronisation therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Assistant Professor Tomasz Podolecki

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

24 More presentations in this session

Presentation thumbnail
Doctor R. Ilhao Moreira (Lisbon, PT)
Abstract
Presentation thumbnail
Doctor D. Lebedev (Kemerovo, RU)
Presentation thumbnail
Mrs A. Patel (Apex, US)
Abstract Slides
Presentation thumbnail
Doctor M. Cortes Garcia (Madrid, ES)
Abstract Slides
Presentation thumbnail
Doctor P. Van Der Bijl (Cape Town, ZA)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Optimising results of cardiac resynchronisation therapy and clinical results and left ventricular lead placement

The Event

Event poster

ESC Congress 2016

30 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
New onset depression and anxiety in patients with an implantable cardioverter defibrillator during 24 months of follow-up
24 April 2021
thumbnail
Congress Presentation
All patients should be considered for mechanical circulatory support - discussion
1 September 2025
thumbnail
Congress Presentation
Left bundle branch pacing optimized cardiac resynchronization therapy - Dawn of a new era in individualized cardiac resynchronization
13 April 2026
thumbnail
Webinar
Common mechanisms of mood disorders and cardiovascular disease
23 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources